A recent study found that a little-known federal program may be driving up union healthcare costs by as much as $416 million per year. The 340B program was created more than 30 years ago to help safety-net providers serve low-income communities by offering prescription drugs at steep discounts. Over time,

FOR IMMEDIATE RELEASEAugust 7, 2025 Importing foreign prices would undermine life science innovation, eliminate union jobs, and cede ground to China The Pharmaceutical Industry Labor-Management Association (PILMA) expresses deep concern over recent White House actions that aim to implement a “Most Favored Nation” (MFN) pricing policy for prescription drugs. This

July 31, 2025 The Honorable Bill Cassidy, Chairman Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510  The Honorable Bernie Sanders, Ranking Member Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 Dear Chairman Cassidy and Ranking Member Sanders, On behalf of the

June 17, 2025 Research shows the U.S. pharmaceutical industry generated 65 million labor hours and $2.6 billion in wages for skilled union workers who built and maintained advanced pharmaceutical manufacturing facilities across 18 states over the past five years. The Pharmaceutical Industry Labor-Management Association (PILMA) today released groundbreaking research demonstrating